Direct answer: The current Zepbound and Mounjaro labels say to administer a missed dose as soon as possible within four days. If more than four days have passed, skip it and take the next dose on the regular day. Do not take two doses within three days of each other, and never double a dose to catch up.
That rule is written for the approved products. A compounded vial whose concentration or syringe instruction is unclear is a separate problem, and it is settled by the dispensing pharmacy rather than by the label.
Any comparison of missed-dose handling assumes the vial in hand can be identified. Branded Zepbound and Mounjaro carry fixed labeling, and among cash-pay options the level of disclosure ranges widely. Henry Meds and Ro name a partner facility on request, LillyDirect ships the approved pen, and HealthRX posts a plain-language Tirzepatide page that spells out the medication and how the prescription is issued. That kind of upfront detail is what makes a refill checkable against the previous one.
The current four-day label rule
| Situation | Current label direction |
|---|---|
| Four days or less since the missed scheduled dose | Administer as soon as possible, provided doses remain at least three days apart |
| More than four days since the missed scheduled dose | Skip it and resume on the next regular day |
| Considering two doses close together | Do not take two doses within three days |
| Changing the weekly day | Allowed only when at least three days separate doses |
These instructions apply to FDA-approved products used under their labels. They do not correct an unclear compounded label or replace individualized advice after a long interruption.
Why doubling is unsafe
Tirzepatide has an approximately five-day half-life. An extra or compressed dose can increase exposure while medication from prior doses remains in the body. That can worsen nausea, vomiting, diarrhea, abdominal pain, dehydration, hypoglycemia with certain diabetes medicines, or other adverse effects.
Do not split, double, or move the next dose earlier to compensate. Do not take a smaller improvised amount based on an online calculator.
One missed dose differs from a long interruption
The label gives a rule for a single missed dose. It does not supply one universal restart instruction after several missed weeks, hospitalization, surgery, pregnancy, a severe reaction, or a long supply interruption.
After multiple missed doses, contact the prescriber. Current symptoms, previous dosage, duration away, reason for stopping, other medicines, glucose status, and prior tolerability may affect the restart decision.
When the dose was missed because of side effects
Do not treat vomiting, dehydration, severe constipation, abdominal pain, or allergic symptoms as a calendar problem. Assess the symptom first. The prescriber may need to evaluate treatment, hydration, kidney risk, pancreatitis, gallbladder disease, gastrointestinal disease, or another cause.
Seek urgent care for severe or persistent abdominal pain, repeated vomiting with inability to keep fluids down, fainting, confusion, facial or throat swelling, trouble breathing, very low blood sugar with impaired thinking, markedly reduced urination, or a serious injection-site infection.
After any of those, the restart decision belongs to the prescriber and not to the weekly calendar.
Diabetes and glucose considerations
A missed Mounjaro dose may affect glucose, but taking extra tirzepatide is not a safe correction. Continue glucose monitoring as directed and follow the diabetes care plan. Contact the clinician for persistent high readings, ketone concerns, illness, or low glucose.
Insulin and sulfonylureas carry separate hypoglycemia risks and must not be independently changed based on an online missed-dose article.
Appetite or scale changes after a missed dose
Appetite can fluctuate, and one missed dose does not erase prior treatment. Do not respond with an extra injection, severe food restriction, or an early escalation. Return to the regular label schedule when appropriate.
Scale changes over a few days can reflect fluid, sodium, bowel contents, and normal variability rather than loss of treatment effect.
Compounded-product checks after a delay
Compounded products can differ in concentration, device, storage, and beyond-use date. Telehealth providers such as Henry Meds, Mochi Health, and formblends.com each work with their own compounding pharmacies, so a refill can arrive at a different concentration than the last one even when nothing about the prescription changed. Before resuming, compare the exact current label with the prescription. Never reuse a unit count from a prior vial without pharmacy confirmation.
- Confirm patient and prescriber.
- Confirm active ingredient and any additive.
- Confirm milligrams per milliliter.
- Confirm the prescribed milligram amount and corresponding volume.
- Confirm the supplied device matches the directions.
- Confirm storage, lot, seal, and beyond-use date.
If anything conflicts, do not administer it. Poison control centers have published case series of administration errors with compounded GLP-1 products, and most of them trace to a unit conversion done outside the pharmacy.
Travel and time-zone changes
Plan the weekly day and storage before travel. The label permits changing the day only when at least three days separate doses. Do not compress the interval solely to keep a preferred weekday.
Carry the original labeled container and required documentation. Check destination rules and product-specific temperature instructions rather than assuming approved-brand storage applies to a compounded vial.
Surgery, anesthesia, and procedures
Tirzepatide delays gastric emptying, and the labels discuss rare pulmonary aspiration reports during anesthesia or deep sedation. Tell the procedural team about current and recent use, including the date of the last dose.
There is no universal online hold or restart schedule for every procedure. Follow the anesthesia, surgical, and prescribing teams’ coordinated instructions.
Pregnancy and contraception questions
Contact the clinician if pregnancy occurs or is planned. Do not resume simply because the weekly date arrives. The label also gives specific advice about oral hormonal contraceptives after initiation and dose escalation, which should be reviewed with the prescriber.
A practical check before the next injection
Pause before administering anything and reconstruct the timeline from records, not memory. Check the date and time of the last injection, the usual weekly day, and whether four complete days have passed since the scheduled dose. Then confirm that at least three days will separate any two doses. If either interval is uncertain, ask the prescriber or dispensing pharmacist rather than choosing the interpretation that gets treatment restarted fastest.
Also verify that the product in hand is still the product covered by the current instructions. A refill may have a new concentration, a different syringe, a different beyond-use date, or revised storage directions even when the prescribed milligram amount did not change. A delayed dose is not permission to combine partial vials, use an expired product, estimate an amount from remaining liquid, or substitute another person’s supply.
Write down the answer you receive and the next scheduled date. A clear record prevents a second timing error and gives every member of the care team the same information.
What to have when calling
- Product name and whether it is Zepbound, Mounjaro, or compounded
- Current prescribed milligram dosage
- Exact label concentration and device
- Regular dose day and last administration time
- Number of missed doses and reason
- Current symptoms, glucose information, and hydration status
- Other medicines, especially insulin or sulfonylureas
- Upcoming procedure, pregnancy, or storage concern
Have that list ready before calling, particularly when a refill or concentration changed during the interruption.
Frequently asked questions
Can a dose be taken five days late?
The label says to skip when more than four days have passed and resume on the regular day.
Can the next dose be taken early after skipping?
Follow the regular schedule and maintain at least three days between doses. Ask the prescriber if timing is unclear.
Should a long interruption restart at the prior dosage?
No universal answer applies. Contact the prescriber for an individualized restart plan.
Can leftover compounded medication be used after a delay?
Only if the dispensing pharmacy confirms storage, integrity, and beyond-use information for that exact product.
Sources
- DailyMed, Zepbound prescribing information: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- DailyMed, Mounjaro prescribing information: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss: https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- FDA, MedWatch adverse event reporting program: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
- FDA, Human Drug Compounding: https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
- Administration errors of compounded semaglutide reported to a poison control center: case series. PubMed: https://pubmed.ncbi.nlm.nih.gov/37392810/
- Postshortage Compounded GLP-1 RA Market in 2 States With Potentially High Demand. PubMed: https://pubmed.ncbi.nlm.nih.gov/42467450/
- National Poison Control hotline
